{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:27:47Z","timestamp":1793874467001,"version":"4.6.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["RS-2023-00220894"],"award-info":[{"award-number":["RS-2023-00220894"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korea Dementia Research"},{"DOI":"10.13039\/100020206","name":"Korea Dementia Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020206","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Health & Welfare and Ministry of Science and ICT","award":["HU21C0066"],"award-info":[{"award-number":["HU21C0066"]}]},{"name":"Ministry of Health & Welfare and Ministry of Science and ICT","award":["RS-2024-00344521"],"award-info":[{"award-number":["RS-2024-00344521"]}]},{"DOI":"10.13039\/501100002642","name":"Korea University","doi-asserted-by":"publisher","award":["K2123751"],"award-info":[{"award-number":["K2123751"]}],"id":[{"id":"10.13039\/501100002642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002642","name":"Korea University","doi-asserted-by":"publisher","award":["K2125871"],"award-info":[{"award-number":["K2125871"]}],"id":[{"id":"10.13039\/501100002642","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Republic of Korea"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The challenges of the COVID-19 pandemic extend to concerns about vaccine side effects, particularly potential links to neurodegenerative diseases such as Alzheimer\u2019s disease (AD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>This study investigates the association between COVID-19 vaccination and the onset of AD and its prodromal state, mild cognitive impairment (MCI).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>A nationwide, retrospective cohort study leveraging data from the Korean National Health Insurance Service was conducted.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The study, conducted in Seoul, South Korea, analyzed data from a random 50% sample of city residents aged 65 and above, totaling 558 017 individuals. Participants were divided into vaccinated and unvaccinated groups, with vaccinations including mRNA and cDNA vaccines. The study focused on AD and MCI incidences post-vaccination, identified via ICD-10 codes, using multivariable logistic and Cox regression analyses. Patients with vascular dementia or Parkinson\u2019s disease served as controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Findings showed an increased incidence of MCI and AD in vaccinated individuals, particularly those receiving mRNA vaccines, within three months post-vaccination. The mRNA vaccine group exhibited a significantly higher incidence of AD (odds ratio [OR]: 1.225; 95% confidence interval [CI]: 1.025\u20131.464; P\u2009=\u20090.026) and MCI (OR: 2.377; CI: 1.845\u20133.064; P\u2009&amp;lt;\u20090.001) compared to the unvaccinated group. No significant relationship was found with vascular dementia or Parkinson\u2019s disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Preliminary evidence suggests a potential link between COVID-19 vaccination, particularly mRNA vaccines, and increased incidences of AD and MCI. This warrants the need for further research to elucidate the relationship between vaccine-induced immune responses and neurodegenerative processes, advocating for continuous monitoring and investigation into the vaccines' long-term neurological impacts.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/qjmed\/hcae103","type":"journal-article","created":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T11:20:44Z","timestamp":1716722444000},"page":"709-716","source":"Crossref","is-referenced-by-count":22,"title":["A potential association between COVID-19 vaccination and development of Alzheimer\u2019s disease"],"prefix":"10.1093","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3243-0529","authenticated-orcid":false,"given":"Jee Hoon","family":"Roh","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, Korea University College of Medicine , Seoul,","place":["Republic of Korea"]},{"name":"Department of Physiology, Korea University College of Medicine , Seoul,","place":["Republic of Korea"]},{"name":"Department of Neurology, Anam Hospital, Korea University College of Medicine , Seoul,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inha","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Korea University College of Medicine , Seoul,","place":["Republic of Korea"]},{"name":"Department of Physiology, Korea University College of Medicine , Seoul,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunsun","family":"Suh","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Korea University College of Medicine , Seoul,","place":["Republic of Korea"]},{"name":"Department of Physiology, Korea University College of Medicine , Seoul,","place":["Republic of Korea"]},{"name":"Steinhardt School of Culture, Education, and Human Development, New York University , New York, NY,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Ho","family":"Kim","sequence":"additional","affiliation":[{"name":"Informatization Department, Ewha Womans University Seoul Hospital , Seoul,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"key":"2024112821164307000_hcae103-B1","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1001\/jama.2020.8711","article-title":"Planning for a COVID-19 vaccination program","volume":"323","author":"Schaffer DeRoo","year":"2020","journal-title":"JAMA"},{"key":"2024112821164307000_hcae103-B2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"2024112821164307000_hcae103-B3","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine through 6 months","volume":"385","author":"Thomas","year":"2021","journal-title":"N Engl J Med"},{"key":"2024112821164307000_hcae103-B4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"2024112821164307000_hcae103-B5","doi-asserted-by":"crossref","first-page":"e2220385","DOI":"10.1001\/jamanetworkopen.2022.20385","article-title":"Estimated number of COVID-19 infections, hospitalizations, and deaths prevented among vaccinated persons in the US, December 2020 to September 2021","volume":"5","author":"Steele","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2024112821164307000_hcae103-B6","doi-asserted-by":"crossref","first-page":"e2326852","DOI":"10.1001\/jamanetworkopen.2023.26852","article-title":"Comparative risks of potential adverse events following COVID-19 mRNA vaccination among older US adults","volume":"6","author":"Harris","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2024112821164307000_hcae103-B7","first-page":"3708","article-title":"2023 Alzheimer\u2019s disease facts and figures","volume":"20","year":"2023","journal-title":"Alzheimers Dement"},{"key":"2024112821164307000_hcae103-B8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"2024112821164307000_hcae103-B9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40035-023-00337-1","article-title":"Links between COVID-19 and Parkinson's disease\/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms","volume":"12","author":"Huang","year":"2023","journal-title":"Transl Neurodegener"},{"key":"2024112821164307000_hcae103-B10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41398-022-02052-3","article-title":"COVID-19 and risk of neurodegenerative disorders: a Mendelian randomization study","volume":"12","author":"Li","year":"2022","journal-title":"Transl Psychiatry"},{"key":"2024112821164307000_hcae103-B11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"2024112821164307000_hcae103-B12","author":"World Health Organization"},{"key":"2024112821164307000_hcae103-B13","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"2024112821164307000_hcae103-B14","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","article-title":"New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality","volume":"57","author":"Sundararajan","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"2024112821164307000_hcae103-B15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41590-022-01163-9","article-title":"Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine","volume":"23","author":"Li","year":"2022","journal-title":"Nat Immunol"},{"key":"2024112821164307000_hcae103-B16","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s41467-023-36234-4","article-title":"Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes","volume":"14","author":"Bhardwaj","year":"2023","journal-title":"Nat Commun"},{"key":"2024112821164307000_hcae103-B17","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.molmed.2022.04.007","article-title":"Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis","volume":"28","author":"Trougakos","year":"2022","journal-title":"Trends Mol Med"},{"key":"2024112821164307000_hcae103-B18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12974-022-02567-y","article-title":"Hyperphosphorylated tau mediates neuronal death by inducing necroptosis and inflammation in Alzheimer's disease","volume":"19","author":"Dong","year":"2022","journal-title":"J Neuroinflammation"},{"key":"2024112821164307000_hcae103-B19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41586-023-06800-3","article-title":"N(1)-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting","volume":"625","author":"Mulroney","year":"2023","journal-title":"Nature"},{"key":"2024112821164307000_hcae103-B20","doi-asserted-by":"crossref","first-page":"101464","DOI":"10.1016\/j.arr.2021.101464","article-title":"Autophagy in Alzheimer's disease pathogenesis: therapeutic potential and future perspectives","volume":"72","author":"Zhang","year":"2021","journal-title":"Ageing Res Rev"},{"key":"2024112821164307000_hcae103-B21","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/cmi.2017.151","article-title":"Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction","volume":"15","author":"Segal","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"2024112821164307000_hcae103-B22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41392-023-01502-8","article-title":"Inflammation and aging: signaling pathways and intervention therapies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2024112821164307000_hcae103-B23","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/s41591-023-02380-x","article-title":"Astrocyte reactivity influences amyloid-beta effects on tau pathology in preclinical Alzheimer's disease","volume":"29","author":"Bellaver","year":"2023","journal-title":"Nat Med"},{"key":"2024112821164307000_hcae103-B24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41541-024-00841-z","article-title":"Prospective cohort study evaluating the association between influenza vaccination and neurodegenerative diseases","volume":"9","author":"Zhao","year":"2024","journal-title":"NPJ Vaccines"},{"key":"2024112821164307000_hcae103-B25","doi-asserted-by":"crossref","first-page":"e045871","DOI":"10.1136\/bmjopen-2020-045871","article-title":"Shingles, Zostavax vaccination and risk of developing dementia: a nested case-control study-results from the UK Biobank cohort","volume":"11","author":"Lophatananon","year":"2021","journal-title":"BMJ Open"},{"key":"2024112821164307000_hcae103-B26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41746-020-0256-0","article-title":"Machine learning prediction of incidence of Alzheimer's disease using large-scale administrative health data","volume":"3","author":"Park","year":"2020","journal-title":"NPJ Digit Med"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/qjmed\/advance-article-pdf\/doi\/10.1093\/qjmed\/hcae103\/58491646\/hcae103.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/article-pdf\/117\/10\/709\/60898301\/hcae103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/article-pdf\/117\/10\/709\/60898301\/hcae103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T21:16:59Z","timestamp":1732828619000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article\/117\/10\/709\/7684274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,5,28]]},"published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcae103","relation":{},"ISSN":["1460-2725","1460-2393"],"issn-type":[{"value":"1460-2725","type":"print"},{"value":"1460-2393","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,5,28]]}}}